JosephALucciIIIMD
Obstetrics & Gynecology • Houston, TXGynecologic Oncology
Professor of Obstetrics & Gynecology, University of Texas Health Science Center at Houston
Dr. Lucci is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11914 Astoria Blvd
Ste 510
Houston, TX 77089Phone+1 713-486-1170Fax+1 713-500-0508
Education & Training
University of California (Irvine)Fellowship, Gynecologic Oncology, 1988 - 1992- University of California (Irvine)Residency, Obstetrics and Gynecology, 1988 - 1992
Methodist Hospital (Houston)Residency, Obstetrics and Gynecology, 1984 - 1988
McGovern Medical School at UTHealthClass of 1984
Certifications & Licensure
CA State Medical License 1988 - Present
FL State Medical License 2004 - 2026
TX State Medical License 1985 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer Start of enrollment: 2003 Sep 01
- Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy Start of enrollment: 2007 Oct 01
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Publications & Presentations
PubMed
- 3 citationsA phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi
International Journal of Gynecological Cancer. 2023-09-04 - 1 citationsThe value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.Lan Zheng, Lin Zhang, Xiaohong Iris Wang, Guy Katz, Nidhi Tandon
Human Pathology. 2022-06-01 - 8 citationsPhase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancerArlene E. Garcia-Soto, Nathalie D. McKenzie, Margaret Whicker, J.M. Pearson, Edward A. Jimenez
Cancer. 2021-07-01
Press Mentions
Thanks to Children's Memorial Hermann Hospital, a Mother's Scary Pregnancy Complication Has a Sweet EndingApril 12th, 2023
Grant Support
- Taxol With Radiotherapy For Carcinoma Of The CervixNational Center For Research Resources1998–1999
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
